Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Trajan Group HoldingsTRJNF 38 OCF Yield % is 10.09 as of Jul. 14, 2026, which is 62% above its 10-year median of 6.23. GuruFocus rates TRJNF with a GF Score™ of 38/100 and a GF Value™ of $1.53. The stock has 2 warning signs investors should review. Among 852 Medical Devices & Instruments companies, Trajan Group Holdings ranks better than 86.62% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Trajan Group Holdings OCF Yield % Related Terms
Trajan Group Holdings OCF Yield % Historical Data
* Premium members only.
The historical data trend for Trajan Group Holdings's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Trajan Group Holdings's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Trajan Group Holdings OCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Trajan Group Holdings's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Trajan Group Holdings's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Trajan Group Holdings (TRJNF) has a OCF Yield % of 10.09 as of Jul. 14, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Trajan Group Holdings and its competitors. This is 62% above median its historical median of 6.23. Over the past decade, Trajan Group Holdings' OCF Yield % has ranged from 0.86 to 35.57. According to the industry distribution chart, Trajan Group Holdings ranks #114 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 13.4%.
Is Trajan Group Holdings' OCF Yield % too high?
Trajan Group Holdings' current OCF Yield % of 10.09 is 62% above median its 10-year median of 6.23. Over the past 10 years, this metric has ranged from a low of 0.86 to a high of 35.57. The Medical Devices & Instruments industry median OCF Yield % is 1.72. Trajan Group Holdings' value of 10.09 is 488.3% above this industry median. Based on the distribution chart, Trajan Group Holdings ranks #114 out of 852 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Trajan Group Holdings has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Trajan Group Holdings' OCF Yield % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Trajan Group Holdings ranks #114 out of 852 companies for OCF Yield %. This places Trajan Group Holdings in the top 13% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 1.72. Trajan Group Holdings' value of 10.09 is 488.3% above this benchmark. Historically, Trajan Group Holdings' own OCF Yield % has ranged from 0.86 to 35.57 over the past decade. While the company's 10-year median is 6.23 vs. the industry median of 1.72, Trajan Group Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Devices & Instruments company?
The median OCF Yield % among Medical Devices & Instruments companies is 1.72, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Trajan Group Holdings's current OCF Yield % of 10.09 is 488.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Trajan Group Holdings and its competitors. For the Medical Devices & Instruments industry, the median OCF Yield % is 1.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Trajan Group Holdings's current OCF Yield % is 10.09, which is 62% above median its own 10-year median of 6.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trajan Group Holdings stock overvalued right now?
Trajan Group Holdings (TRJNF) has a current OCF Yield % of 10.09. The stock's GF Value™ is $1.53, compared to a current price of $0.40 — trading 73.9% below its estimated fair value. The current OCF Yield % is 10.09, which is 62% above median its 10-year median of 6.23 and 488.3% above the Medical Devices & Instruments industry median of 1.72. Trajan Group Holdings' overall GF Score™ is 38/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Trajan Group Holdings (TRJNF), the current OCF Yield % is 10.09 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Trajan Group Holdings (TRJNF) Overvalued in 2026?
Based on GuruFocus' analysis, Trajan Group Holdings stock appears to be undervalued.
The current stock price of $0.40 is trading 73.9% below its estimated GF Value™ of $1.53.
Key valuation signals for TRJNF:
OCF Yield %: 10.09 (62% above median its 10-year median of 6.23)
GF Value™: $1.53 vs. price of $0.40 (73.9% below fair value)
Industry Position: 488.3% above the Medical Devices & Instruments median (#114 of 852)
No single metric tells the full story. See the TRJNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Trajan Group Holdings Ltd is a developer and manufacturer of analytical and life sciences products and devices, seeking to enrich human well-being through scientific measurement. Its current portfolio of products comprises products, devices and solutions that are used in the analysis of biological, food, and environmental samples. The Group now reports in three operating segments: Components and Consumables, Capital Equipment and Disruptive Technologies. Key revenue is generated from Components and consumables, which include parts, supplies, components, and consumable products worldwide. The Group operates in Asia (Malaysia, Japan and Australia and New Zealand (ANZ)), USA and Europe, Middle East, Africa, and India (EMEA).
38GF Score
Get the complete analysis for TRJNF
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TRJNF has been successfully added to your 
